References

1. Lemmen, C., Hiller, C. and Lengauer, T.: J. Computer-Aided Mol. Design, 12 (1998) 491.

2. Mestres, J., Rohrer, D.C. and Maggiora, G.M., J. Mol. Graph. Model., 15 (1997) 114.

4. Crippen, G.M. and Havel, T.F., Distance Geometry and Molecular Conformation, Research Studies Press, Taunton, U.K., 1988.

5. Marshall, G.R., Barry, C.D., Bosshard, H.D., Dammkoehler, R.D. and Dunn, D.A., In Olson, E.C. and Christoffersen, R.E. (Eds.), Computer-Assisted Drug Design, Vol. 112, American Chemical Society, Washington, DC, U.S.A., 1979, pp. 205-222.

6. Takahashi, Y., Maeda, S. and Sasaki, S.-I., Anals Chimica Acta, 200 (1987) 363.

7. Martin, Y.C., Bures, M.G., Danaher, E.A., DeLazzer, J., Lico, I. and Pavlik, P.A., J. Cornput.-Aided Mol. Design, 7 (1992) 83.

8. Lamdan, Y. and Wolfson, H.J., In IEEE International Conference on Computer Vision, Tampa, FL, 1988, pp. 238-249.

9. Nussinov, R. and Wolfson, H.J., Proc. Natl. Acad. Sci. USA, 88 (1991) 10495.

11. Hurst, T., J. Chem. Inf. Comput. Sci., 34 (1994) 190.

12. Carbö, R., Leyda, L. and Amau, M., Int. J. Quant. Chem., 17 (1980) 1185.

13. Hodgkin, E.E. and Richards, G., Int. J. Quant. Chem., Quant. Biol. Symp., 14 (1987) 105.

14. Thomer, D.A., Wild, D.J., Willett, P. and Wright, P.M., J. Chem. Inf. Comput. Sci., 36 (1 996) 900.

15. Lemmen, C., Lengauer, T. and Klebe, G., J. Med. Chem., 41 (1998) 4502.

16. Hahn, M., J. Chem. Inf. Comput. Sci., 37 (1997) 80.

17. Wang, T. and Zhou, J., J. Chem. Inf. Comput. Sci., 38 (1998) 71.

18. Brint, A.T. and Willett, P., J. Chem. Inf. Comput. Sci., 27 (1997) 152.

19. Martin, Y.C., Bures, M.G. and Willett, P., In Lipkowitz, B. and Boyd, D.B. (Eds.), Reviews in Computational Chemistry, VCH, Weinheim, Germany, 1990, pp. 265-294.

20. Johnson, M.A. and Maggiora, G.M. (Eds.), Concepts and Applications of Molecular Similarity, John Wiley & Sons, New York, NY, U.S.A., 1990.

21. Kubinyi, H. (Ed.), 3D QSAR in Drug Design. Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993.

22. Dean, P.M., In Dean, P.M. (Ed.), Molecular Similarity in Drug Design, Blackie Academic & Professional, London, U.K., 1995, pp. 1-23.

23. Good, A.C., In Dean, P.M. (Ed.), Molecular Similarity in Drug Design, Blackie Academic & Professional, London, U.K., 1995, pp. 24-56.

24. Humblet, C. and Dunbar Jr., J.B., In Venuti, M.C. (Ed.), Annual Reports in Medicinal Chemistry, Vol. 28, Chapter VI: Topics in Drug Design and Discovery,Academic Press, London, U.K., 1993, pp. 275-284.

25. Klebe, G., In Kubinyi, H. (Ed.), 3D QSAR in Drug Design. Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993, pp. 173-199.

27. Brown, R.D. and Martin, Y.C., J. Chem. Inf. Comput. Sci., 36 (1996) 572.

28. Bures, M.G., In Charifson, P.S. (Ed.), Practical Application of Computer-aided Drug Design, Marcel Dekker, New York, NY, U.S.A., 1997, pp. 39-72.

29. Matter, H. and Rarey, M., In Jung, G. (Ed.), Combinatorial Organic Chemistry, Wiley-VCH, Weinheim, 2000.

30. Lernmen, C. and Lengauer, T., J. Cornput.-Aided Mol. Design, 14 (2000) 215.

31. Klebe, G., Mietzner, T. and Weber, F., J. Cornput.-Aided Mol. Design, 8 (1994) 751.

32. Nissink, J.W.M., Verdonk, M.L., Kroon, J., Mietzner, T. and Klebe, G., J. Comput. Chem., 18 (1997) 638.

33. Lemmen, C. and Lengauer, T., J. Comput.-Aided Mol. Design, 11 (1997) 357.

34. Lernmen, C., Computational Methods for the Structural Alignment of Molecules. Number 1 in GMD Research Series. GMD - Forschungszentrum Informationstechnik, Sankt Augustin, Germany, 1999.

35. Jones, G., Willett, P., Glen, R.C. and Taylor, R., J. Mol. Biol., 267 (1997) 727.

36. Kramer, B., Rarey, M. and Lengauer, T., Proteins Struct. Funct. Genet., 37 (1999) 1.

37. DAYLIGHT Inc., Mission Viejo, CA, U.S.A. DAYLIGHT Software Manual, 1994.

38. Briem, H. and Kuntz, I.D., J. Med. Chem., 39 (1996) 3401.

39. MDL Information Systems Inc., San Leandro, CA, U.S.A. MACCS Drug Data Report (MDDR).

40. NCI DB release (http://dtp.nci.nih.gov/docs/3d_database/strucural_information/-structural_data.html, containing 126,710 structures, 07/01/1998. After conversion to SYBYL's mol2 format and validation 121,491 structures remained.

Perspectives in Drug Discovery and Design, 20: 63-81, 2000. KLUWER/ESCOM

© 2000 Kluwer Academic Publishers. Printed in the Netherlands.

0 0

Post a comment